Previsioni di mercato della bioproduzione nell\'Asia del Pacifico fino al 2030 - Analisi regionale - per prodotto (prodotti biologici e biosimilari, vaccini, terapie cellulari e genetiche, terapie con acidi nucleici e altri), applicazione (artrite reumatoide, disturbi ematologici, cancro, diabete, malattie cardiovascolari e altri) ), apparecchiature (apparecchiature a monte, apparecchiature a valle, bioreattori, materiali di consumo e accessori) e utente finale (aziende biofarmaceutiche, organizzazioni di produzione a contratto e altri)
La scadenza del brevetto dei prodotti biologici di successo stimola il mercato della bioproduzione nell\'Asia del Pacifico
I prodotti biologici rappresentano nuove terapie promettenti per malattie precedentemente incurabili e stanno diventando molto importanti nel mercato farmaceutico. Si prevede che i brevetti sui prodotti biologici originali scadranno nei prossimi anni.
Le date di scadenza stimate dei brevetti e dell\'esclusività per i prodotti biologici più venduti sono riportate nella tabella seguente.
Date di scadenza dei prodotti biologici
Date di scadenza dei prodotti biologici
Avastin
Gennaio 2022
Cyramza
Maggio 2023
Adcetris
Agosto 2023
Abthrax < br> Ottobre 2024
Gazyva/Gazyvaro
Novembre 2024
Darzalex
Maggio 2026
Ocrevus
Aprile 2027
Emgality
Settembre 2028
Hemlibra
Febbraio 2028
Llumetri
Marzo 2028
Imfinzi
Settembre 2028
Mylotarg
Aprile 2028
Imfinzi
Settembre 2028
Mylotarg
Aprile 2028
Sylvant
Luglio 2034
La scadenza del brevetto e altri diritti di proprietà intellettuale per i prodotti biologici originali creeranno la necessità di introdurre nuovi biosimilari in futuro. Di conseguenza, nei prossimi anni la concorrenza tra gli operatori del mercato aumenterà nel settore. Pertanto, si prevede che la scadenza dei brevetti dei prodotti biologici di successo creerà opportunità redditizie per il mercato della bioproduzione durante il periodo di previsione.
Panoramica del mercato della bioproduzione nell\'Asia del Pacifico
Il mercato della bioproduzione nell\'Asia del Pacifico è segmentato in Cina, Giappone, India, Corea del Sud, Australia, Corea del Sud e resto dell\'Asia del Pacifico. Si prevede che la crescita del mercato nell’Asia del Pacifico crescerà a un ritmo più rapido a causa di fattori quali la crescente necessità di soluzioni di trattamento superiori, la crescente attenzione alle attività di ricerca e sviluppo e scenari normativi favorevoli. Inoltre, si stima che l’aumento degli investimenti e lo sviluppo delle infrastrutture sanitarie per potenziare le attività di ricerca guideranno il mercato della bioproduzione nell’Asia del Pacifico nel periodo 2022-2030.
In Cina, la domanda di assistenza sanitaria è in rapido aumento. Fattori come la crescita della popolazione geriatrica, la crescente incidenza di malattie croniche e le crescenti iniziative governative nel settore sanitario stanno guidando il mercato della terapia cellulare in Cina. Anche i miglioramenti nei piani di assicurazione medica di base e privata hanno accelerato la crescita del settore medico nel paese. L’aumento dei livelli di reddito ha portato alla domanda di servizi sanitari più sofisticati. L’aumento della popolazione geriatrica ha portato ad un aumento della comunità medica specialistica nel paese. In Cina, la crescente prevalenza del cancro probabilmente aumenterà l’adozione della terapia cellulare. Secondo il Registro centrale nazionale dei tumori della Cina, in Cina sono stati registrati 4,3 milioni di nuovi casi di cancro.
Entrate e previsioni del mercato della bioproduzione nell\'Asia del Pacifico fino al 2030 (milioni di dollari)
Segmentazione del mercato della bioproduzione nell\'Asia del Pacifico
Il mercato della bioproduzione nell\'Asia del Pacifico è classificato in prodotto, applicazione, attrezzatura, utente finale e paese.
In base al prodotto, il mercato della bioproduzione dell\'Asia Pacifico è segmentato in prodotti biologici e biosimilari, vaccini, terapie cellulari e geniche, terapie con acidi nucleici e altri. Il segmento dei prodotti biologici e biosimilari ha detenuto la maggiore quota di mercato della bioproduzione nell\'Asia del Pacifico nel 2022.
In termini di applicazione, il mercato della bioproduzione dell\'Asia del Pacifico è segmentato in artrite reumatoide, disturbi ematologici, cancro, diabete, malattie cardiovascolari e altri. Il segmento del cancro deteneva la maggiore quota di mercato della bioproduzione nell’Asia del Pacifico nel 2022.
In base alle apparecchiature, il mercato della bioproduzione nell\'Asia del Pacifico è suddiviso in apparecchiature a monte, apparecchiature a valle, bioreattori e materiali di consumo e accessori. Il segmento dei materiali di consumo e degli accessori ha detenuto la quota maggiore del mercato della bioproduzione dell\'Asia del Pacifico nel 2022.
In termini di utente finale, il mercato della bioproduzione dell\'Asia del Pacifico è classificato in aziende biofarmaceutiche, organizzazioni di produzione a contratto e altri. Il segmento delle aziende biofarmaceutiche deteneva la maggiore quota di mercato della bioproduzione nell\'Asia del Pacifico nel 2022.
Per paese, il mercato della bioproduzione nell\'Asia del Pacifico è segmentato in Australia, Cina, India, Giappone, Corea del Sud e resto dell\'Asia del Pacifico. La Cina ha dominato la quota di mercato della bioproduzione nell\'Asia del Pacifico nel 2022.
Lonza Group AG, bbi-biotech GmbH, Danaher Corp, Sartorius AG, FUJIFILM Irvine Scientific Inc, Thermo Fisher Scientific Inc, Merck KGaA, F. Hoffmann-La Roche Ltd, e Bio-Rad Laboratories Inc. sono alcune delle aziende leader che operano nel mercato della bioproduzione dell\'Asia del Pacifico.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Bioproduction Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. Bioproduction Market - Asia Pacific Market Analysis
5.1 Asia Pacific Bioproduction Market Revenue (US$ Mn), 2020 - 2030
6. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Product
6.1 Overview
6.2 Asia Pacific Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 Asia Pacific Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by Equipment
8.1 Overview
8.2 Asia Pacific Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Asia Pacific: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 Asia Pacific Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis
10.1 Asia Pacific: Bioproduction Market
10.1.1 Asia Pacific: Bioproduction Market, by Country, 2022 & 2030 (%)
10.1.1.1 China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.2 China: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.1.3 China: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.4 China: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.1.4.1 China: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.1.5 China: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 India: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.4 India: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.5 India: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.2.5.1 India: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.2.6 India: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 Japan: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.3.4 Japan: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.5 Japan: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.3.5.1 Japan: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.3.6 Japan: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.4 Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Australia: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.4 Australia: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.4.5 Australia: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.4.5.1 Australia: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.4.6 Australia: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.5 South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 South Korea: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.5.4 South Korea: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.5.5 South Korea: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.5.5.1 South Korea: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.5.6 South Korea: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.6.5.1 Rest of Asia Pacific: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.6.6 Rest of Asia Pacific: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
11. Bioproduction Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 . Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 bbi-biotech GmbH
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Danaher Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sartorius AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 FUJIFILM Irvine Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 F. Hoffmann-La Roche Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bio-Rad Laboratories Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
?
List of Tables
Table 1. Asia Pacific Bioproduction Market Segmentation
Table 2. Asia Pacific Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. China Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. China Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. China Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. China Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 7. China Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. India Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. India Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. India Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. India Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 12. India Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Japan Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. Japan Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. Japan Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 16. Japan Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 17. Japan Bioproduction Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 18. Australia Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 19. Australia Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 20. Australia Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 21. Australia Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 22. Australia Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 23. South Korea Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 24. South Korea Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. South Korea Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 26. South Korea Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 27. South Korea Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 28. Rest of Asia Pacific Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 29. Rest of Asia Pacific Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 30. Rest of Asia Pacific Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Asia Pacific Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Asia Pacific Bioproduction Market, by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 33. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 34. Recent Organic Growth Strategies in the Bioproduction Market
Table 35. Glossary of Terms, Bioproduction Market
?
List of Figures
Figure 1. Asia Pacific Bioproduction Market Segmentation, By Country
Figure 2. Asia Pacific Bioproduction Market: Key Industry Dynamics
Figure 3. Asia Pacific Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Asia Pacific Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Asia Pacific Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Asia Pacific Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Asia Pacific Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Asia Pacific Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Asia Pacific: Bioproduction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. Asia Pacific: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. China: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. India: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Japan: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Australia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. South Korea: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. Rest of Asia Pacific: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 35. Growth Strategies in the Bioproduction Market
1. Lonza Group AG
2. bbi-biotech GmbH
3. Danaher Corp
4. Sartorius AG
5. FUJIFILM Irvine Scientific Inc
6. Thermo Fisher Scientific Inc
7. Merck KGaA
8. F. Hoffmann-La Roche Ltd
9. Bio-Rad Laboratories Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific bioproduction market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific bioproduction market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.